dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Van Cutsem, Eric |
dc.contributor.author | Danielewicz, I. |
dc.contributor.author | Saunders, M. P. |
dc.contributor.author | Pfeiffer, P. |
dc.contributor.author | Argilés Martinez, Guillem |
dc.contributor.author | Borg, Christophe |
dc.date.accessioned | 2021-10-19T10:58:36Z |
dc.date.available | 2021-10-19T10:58:36Z |
dc.date.issued | 2020-09 |
dc.identifier.citation | Van Cutsem E, Danielewicz I, Saunders MP, Pfeiffer P, Argilés G, Borg C, et al. Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study. Ann Oncol. 2020 Sep;31(9):1160–8. |
dc.identifier.issn | 0923-7534 |
dc.identifier.uri | https://hdl.handle.net/11351/6411 |
dc.description | Bevacizumab; Teràpia intensiva; Càncer colorectal metastàtic |
dc.description.sponsorship | This study was funded by Servier and Taiho. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Annals of Oncology;31(9) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Còlon - Càncer - Quimioteràpia |
dc.subject | Recte - Càncer - Quimioteràpia |
dc.subject | Medicaments antineoplàstics - Ús terapèutic |
dc.subject.mesh | Colorectal Neoplasms |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols |
dc.title | Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.annonc.2020.05.024 |
dc.subject.decs | neoplasias colorrectales |
dc.subject.decs | protocolos de quimioterapia antineoplásica combinada |
dc.relation.publishversion | https://doi.org/10.1016/j.annonc.2020.05.024 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Van Cutsem E] University Hospitals Leuven and KU Leuven, Leuven, Belgium. [Danielewicz I] Szpitale Wojewodzkie w Gdyni/Gdansk Medical University, Gdynia, Poland. [Saunders MP] Christie Hospital NHS Foundation Trust, Manchester, UK. [Pfeiffer P] Odense University Hospital, Odense, Denmark. [Argilés G] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Borg C] University Hospital Besançon, Besançon, France |
dc.identifier.pmid | 32497736 |
dc.identifier.wos | 000562396600011 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |